Isolation of cholesterol-dependent, multidrug-resistant Candida glabrata strains from blood cultures of a candidemia patient in Kuwait

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Khan, Ziauddin ^a   Ahmad, Suhail ^a   Joseph, Leena ^a   Al Obaid, Khaled ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL AMIRI HOSPITAL   (Kuwait)

Author keywords

Candida glabrata; Candidemia; Cholesterol auxotrophy; Drug resistance

Indexed keywords

AMPHOTERICIN B; BILE EXTRACT; CASPOFUNGIN; CHOLESTEROL; ERGOSTEROL; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD CULTURE; CANDIDA GLABRATA; CANDIDEMIA; ERG11 GENE; ERG3 GENE; FUNGAL GENE; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENE MUTATION; GENE SEQUENCE; KUWAIT; LIPOGENESIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; DRUG EFFECTS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTIFUNGAL AGENTS; CANDIDA GLABRATA; CANDIDEMIA; CHOLESTEROL; DRUG RESISTANCE, MULTIPLE, FUNGAL; HUMANS; KUWAIT; MICROBIAL SENSITIVITY TESTS;

EID: 84899490744     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-188     Document Type: Article

References (20)

1. Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis 2012, 73:45-48. 10.1016/j.diagmicrobio.2012.02.001, 22578938.
2. Pfaller MA. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med 2012, 125(Suppl):S3-13.
3. Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chemother 2005, 49:668-679. 10.1128/AAC.49.2.668-679.2005, 547307, 15673750.
4. Hull CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL. Facultative sterol uptake in an ergosterol-deficient clinical isolate of Candida glabrata harboring a missense mutation in ERG11 and exhibiting cross-resistance to azoles and amphotericin B. Antimicrob Agents Chemother 2012, 56:4223-4232. 10.1128/AAC.06253-11, 3421581, 22615281.
5. Geber A, Hitchcock CA, Swartz JE, Pullen FS, Marsden KE, Kwon-Chung KJ, Bennett JE. Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob Agents Chemother 1995, 39:2708-2717. 10.1128/AAC.39.12.2708, 163017, 8593007.
6. Khan ZU, Ahmad S, Hagen F, Fell JW, Kowshik T, Chandy R, Boekhout T. Cryptococcus randhawai sp. nov., a novel anamorphic basidiomycetous yeast isolated from tree trunk hollow of Ficus religiosa (peepal tree) from New Delhi, India. Antonie Van Leeuwenhoek 2010, 97:253-259. 10.1007/s10482-009-9406-8, 20091225.
7. Mokaddas E, Khan ZU, Ahmad S. Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5-year retrospective study. Mycoses 2011, 54:e29-34. 10.1111/j.1439-0507.2009.01822.x, 20002881.
8. Asadzadeh M, Ahmad S, Al-Sweih N, Khan ZU. Rapid molecular differentiation and genotypic heterogeneity among Candida parapsilosis and Candida orthopsilosis strains isolated from clinical specimens in Kuwait. J Med Microbiol 2009, 58(Pt 6):745-752.
9. Pfaller MA, Diekema DJ. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J Clin Microbiol 2012, 50:2846-2856. 10.1128/JCM.00937-12, 3421803, 22740712.
10. Bard M, Sturm AM, Pierson CA, Brown S, Rogers KM, Nabinger S, Eckstein J, Barbuch R, Lees ND, Howell SA, Hazen KC. Sterol uptake in Candida glabrata: rescue of sterol auxotrophic strains. Diagn Microbiol Infect Dis 2005, 52:285-293. 10.1016/j.diagmicrobio.2005.03.001, 15893902.
11. Hazen KC, Stei J, Darracott C, Breathnach A, May J, Howell SA. Isolation of cholesterol-dependent Candida glabrata from clinical specimens. Diagn Microbiol Infect Dis 2005, 52:35-37. 10.1016/j.diagmicrobio.2004.12.006, 15878440.
12. Rezusta A, Aspiroz C, Boekhout T, Cano JF, Theelen B, Guarro J, Rubio MC. Cholesterol-dependent and amphotericin B resistant isolates of a Candida glabrata strain from an Intensive Care Unit patient. Med Mycol 2008, 46:265-268. 10.1080/13693780701636898, 18404554.
13. Khan ZU, Ahmad S, Al-Obaid I, Al-Sweih NA, Joseph L, Farhat D. Emergence of resistance to amphotericin B and triazoles in Candida glabrata vaginal isolates in a case of recurrent vaginitis. J Chemother 2008, 20:488-491. 10.1179/joc.2008.20.4.488, 18676230.
14. Krogh-Madsen M, Arendrup MC, Heslet L, Knudsen JD. Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. Clin Infect Dis 2006, 42:938-944. 10.1086/500939, 16511756.
15. Pfaller MA, Castanheira M, Lockhart SR, Ahlquist AM, Messer SA, Jones RN. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol 2012, 50:1199-1203. 10.1128/JCM.06112-11, 3318516, 22278842.
16. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD. Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:503-535. 10.1086/596757, 19191635.
17. Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD, Rogers PD. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Mol Microbiol 2006, 61:704-722. 10.1111/j.1365-2958.2006.05235.x, 16803598.
18. Tsai HF, Sammons LR, Zhang X, Suffis SD, Su Q, Myers TG, Marr KA, Bennett JE. Microarray and molecular analyses of the azole resistance mechanism in Candida glabrata oropharyngeal isolates. Antimicrob Agents Chemother 2010, 54:3308-3317. 10.1128/AAC.00535-10, 2916311, 20547810.
19. Farahyar S1, Zaini F, Kordbacheh P, Rezaie S, Safara M, Raoofian R, Heidari M. Overexpression of aldo-keto-reductase in azole-resistant clinical isolates of Candida glabrata determined by cDNA-AFLP. Daru 2013, 21:1. 10.1186/2008-2231-21-1, 3556022, 23351326.
20. Lewis JS, Wiederhold NP, Wickes BL, Patterson TF, Jorgensen JH. Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure. Antimicrob Agents Chemother 2013, 57:4559-4561. 10.1128/AAC.01144-13, 3754289, 23817368.